New US Lab Panel Targets Hard-to-Diagnose Liver Fluke Infections
The 3-test panel detects antibodies for parasitic infections that affect up to 45 million people globally and are linked to bile duct cancer.
Latest Articles
Editor's Top Picks
What Clinical Lab Leaders Predict for 2026
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
FDA Grants Breakthrough Device Designation for Hemoglobin Variant Test
The test uses miniaturized electrophoresis technology designed to enable decentralized access to quantitative hemoglobin data.
Equipment & Supply Spotlight
FDA Warns of False Positive Lead Test Results with Certain Blood Collection Tubes
The FDA has warned of falsely elevated lead test results when using ASP Global’s SAFE-T-FILL tubes with Magellan Diagnostics LeadCare systems and has issued warning letters to involved manufacturers.
News, Know-How & Standards
Disease Detection & Understanding
Ambry Genetics Expands MAVE Research to PALB2 Gene for Hereditary Cancer Testing
Ambry Genetics supported a new study evaluating 6,718 PALB2 gene variants using MAVEs, advancing risk assessment for hereditary breast and pancreatic cancer.
